SEC Comment Letter for AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Jan 17, 2008

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Jan. 17, 2008 · CIK: 0000946644 · Accession: 0000000000-08-003284

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-13441

Date

January 17, 2008

Author

Jeffrey P. Riedler

Form

UPLOAD

Company

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)

Letter

Mail Stop 6010 January 17, 2008 William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc. 1617 JFK Boulevard Philadelphia, Pennsylvania 19103 Re: Hemispherx Biopharma, Inc. Form 10-K for the Fiscal Year Ended December 31, 2006 File No. 001-13441

Dear Dr. Carter: We have completed our review of your Form 10-K and have no further comments at this time. Sincerely, J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

Show Raw Text

Mail Stop 6010                                                                                                   January 17, 2008   William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc.  1617 JFK Boulevard  Philadelphia, Pennsylvania 19103
Re: Hemispherx Biopharma, Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2006  File No. 001-13441

Dear Dr. Carter:
  We have completed our review of your Form 10-K and have no further comments
at this time.
Sincerely,
           J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

SecProbe.io